Inventor
FISHER PAUL B
US51 patents
⚠️ This page may combine multiple inventors who share the name “FISHER PAUL B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLUMBIA
37 patentsUS6472520B2Oct 29, 2002
Rat PEG-3 promoter
UNIV COLUMBIA45 citations96
US5710137AJan 20, 1998
Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype
UNIV COLUMBIA72 citations96
US5643761AJul 1, 1997
Method for generating a subtracted cDNA library and uses of the generated library
UNIV COLUMBIA92 citations94
US6855686B2Feb 15, 2005
Methods of treating various cancers using melanoma differentiation associated protein
UNIV COLUMBIA14 citations92
US6777180B1Aug 17, 2004
Method for full-length cDNA cloning using degenerate stem-loop annealing primers
UNIV COLUMBIA54 citations92
US6355622B1Mar 12, 2002
Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell
UNIV COLUMBIA22 citations92
US6146877ANov 14, 2000
Identification of the progression elevated gene-3 and uses thereof
UNIV COLUMBIA19 citations92
US5882874AMar 16, 1999
Reciprocal subtraction differential display
UNIV COLUMBIA35 citations92
US6051376AApr 18, 2000
Uses of mda-6
UNIV COLUMBIA25 citations91
US6214544B1Apr 10, 2001
Method to identify tumor suppressor genes
UNIV COLUMBIA15 citations84
US6737523B1May 18, 2004
Nucleic acids comprising regions of the rat PEG-3 promoter that display elevated expression in human cancer cells and uses thereof
UNIV COLUMBIA13 citations81
US5851764ADec 22, 1998
Human prostate tumor inducing gene-1 and uses thereof
UNIV COLUMBIA16 citations76
US6255049B1Jul 3, 2001
Detection of metastatic cancer cells using PCTA-1
UNIV COLUMBIA7 citations74
US6071696AJun 6, 2000
Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation
UNIV COLUMBIA6 citations74
US6720408B2Apr 13, 2004
MDA-7 nucleic acid molecules and pharmaceutical compositions thereof
UNIV COLUMBIA8 citations72
US6187819B1Feb 13, 2001
Protein kinase C activators and their use in decreasing expression of cell antigens
UNIV COLUMBIA10 citations71
US5681860AOct 28, 1997
Method of increasing expression of HLA, cell surface and TAA antigens of cells using 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol
UNIV COLUMBIA9 citations71
US6841362B1Jan 11, 2005
Melanoma differentiation associated gene-7 promoter and uses thereof
UNIV COLUMBIA6 citations66
US6440741B2Aug 27, 2002
Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
UNIV COLUMBIA8 citations66
US7339026B2Mar 4, 2008
mda-9 protein
UNIV COLUMBIA1 citations63
US6869760B2Mar 22, 2005
Use of prostate tumor inducing gene for detection of cancer cells
UNIV COLUMBIA3 citations63
US6677152B2Jan 13, 2004
Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
UNIV COLUMBIA4 citations63
US6548650B1Apr 15, 2003
Nucleic acid encoding melanoma differentiation associated gene-9
UNIV COLUMBIA2 citations63
US6184032B1Feb 6, 2001
Identification of genes encoding cell surface antigens using CREF-Trans 6 cells
UNIV COLUMBIA5 citations63
US6159751ADec 12, 2000
Development of DNA probes and immunological reagents of human tumor associated antigens
UNIV COLUMBIA3 citations63
US7507792B2Mar 24, 2009
MDA-7 proteins and methods of use thereof
UNIV COLUMBIA4 citations61
US6204001B1Mar 20, 2001
Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene
UNIV COLUMBIA2 citations60
US6069174AMay 30, 2000
Protein kinase C activators and their use in increasing expression of cell antigens
UNIV COLUMBIA2 citations60
US7579330B2Aug 25, 2009
Methods of treating various cancers using melanoma differentiation associated protein-7
UNIV COLUMBIA0 citations52
US7449565B2Nov 11, 2008
Chimeric tumor suppressor gene and protein
UNIV COLUMBIA1 citations52
US7291605B2Nov 6, 2007
Methods of treating various cancers using melanoma differentiation associated protein-7
UNIV COLUMBIA0 citations52
US6657053B1Dec 2, 2003
Reciprocal subtraction differential display
UNIV COLUMBIA0 citations52
US7329649B2Feb 12, 2008
Combinatorial methods for inducing cancer cell death
UNIV COLUMBIA1 citations49
US6982148B2Jan 3, 2006
Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis
UNIV COLUMBIA0 citations49
US7229822B1Jun 12, 2007
Melanoma differentation associated gene-5 and vectors and cells containing same
UNIV COLUMBIA0 citations46
US6951923B2Oct 4, 2005
Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
UNIV COLUMBIA1 citations43
US6811972B1Nov 2, 2004
Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
UNIV COLUMBIA0 citations42
UNIV VIRGINIA COMMONWEALTH
8 patentsUS11891399B2Feb 6, 2024
Inhibitors of cancer invasion, attachment, and/or metastasis
UNIV VIRGINIA COMMONWEALTH1 citations56
US11008325B2May 18, 2021
Inhibitors of cancer invasion, attachment, and/or metastasis
UNIV VIRGINIA COMMONWEALTH1 citations56
US12325863B2Jun 10, 2025
MDA-7/IL-24 secretory variants and methods of use
UNIV VIRGINIA COMMONWEALTH0 citations55
US10166300B2Jan 1, 2019
Tripartite cancer theranostic nucleic acid constructs
UNIV VIRGINIA COMMONWEALTH0 citations49
US9701985B2Jul 11, 2017
mda-9/syntenin promoter to image and treat metastatic cancer cells
UNIV VIRGINIA COMMONWEALTH0 citations48
US9951114B2Apr 24, 2018
Recombinant cancer therapeutic cytokine
UNIV VIRGINIA COMMONWEALTH0 citations43
US10597728B2Mar 24, 2020
Methylation site regulating expression of mda-9/syntenin
UNIV VIRGINIA COMMONWEALTH0 citations42
US9750823B2Sep 5, 2017
Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics
UNIV VIRGINIA COMMONWEALTH0 citations41
FISHER PAUL B
2 patentsCORIXA CORP
1 patentUNIV JOHNS HOPKINS
1 patentSARKAR DEVANAND
1 patentShowing the top 50 of 51 patents by PatentIndex Score.